Abstract:Background: Ketamine disrupts the proliferation and differentiation of developing neural stem cells (NSCs). Therefore, the safe use of ketamine in pediatric anesthesia has been an issue of increasing concern among anesthesiologists and children's parents. Dexmedetomidine (DEX) is widely used in sedation as an antianxiety agent and for analgesia. DEX has recently been shown to provide neuroprotection against anesthetic-induced neurotoxicity in the developing brain. The aim of this in vivo study was to investigate whether DEX exerted neuroprotective effects on the proliferation and differentiation of NSCs in the subventricular zone (SVZ) following neonatal ketamine exposure. Methods: Postnatal day 7 (PND-7) male Sprague-Dawley rats were equally divided into the following five groups: control group (n = 8), ketamine group (n = 8), 1 μg/kg DEX+ketamine group (n = 8), 5 μg/kg DEX+ketamine group (n = 8) and 10 μg/kg DEX+ketamine group (n = 8). Immediately after treatment, rats received a single intraperitoneal injection of BrdU, and the proliferation and differentiation of NSCs in the SVZ were assessed using immunostaining at 24 h after the BrdU injection. In the olfactory behavioral tests, rats in each group were raised until 2 months old, and the buried food test and olfactory memory test were performed. Results: The proliferation of NSCs and astrocytic differentiation in the SVZ were significantly inhibited at 24 h after repeated ketamine exposure in the neonatal period, and neuronal differentiation was markedly increased. Furthermore, pretreatment with moderately high (5 μg/kg) or high doses (10 μg/kg) of DEX reversed ketamine-induced disturbances in the proliferation and differentiation of NSCs. In the behavior tests, repeated neonatal ketamine exposure induced olfactory cognitive dysfunction in the adult stage, and moderately high and high doses of DEX reversed the olfactory cognitive dysfunction induced by ketamine. Conclusions: Based on the present findings, pretreatment with a moderately high (5 μg/kg) or high dose (10 μg/kg) of DEX may alleviate the developmental neurogenesis disorder in the SVZ at 24 h after repeated ketamine exposure and improve olfactory cognitive dysfunction in adulthood.

17Β-Estradiol Treatment Attenuates Neurogenesis Damage and Improves Behavior Performance after Ketamine Exposure in Neonatal Rats

17β-Estradiol Protects Neural Stem/Progenitor Cells Against Ketamine-Induced Injury Through Estrogen Receptor β Pathway

Mechanisms of Propofol Attenuation of Ketamine-Induced Neonatal Brain Injury

Pretreatment with Minocycline Restores Neurogenesis in the Subventricular Zone and Subgranular Zone of the Hippocampus after Ketamine Exposure in Neonatal Rats.

Long-term neurocognitive dysfunction in offspring via NGF/ ERK/CREB signaling pathway caused by ketamine exposure during the second trimester of pregnancy in rats

Neuroprotective Effects of Dexmedetomidine on the Ketamine-Induced Disruption of the Proliferation and Differentiation of Developing Neural Stem Cells in the Subventricular Zone

Prenatal Exposure to General Anesthesia Drug Esketamine Impaired Neurobehavior in Offspring

Repeated Ketamine Anesthesia during the Neonatal Period Impairs Hippocampal Neurogenesis and Long-Term Neurocognitive Function by Inhibiting Mfn2-Mediated Mitochondrial Fusion in Neural Stem Cells

Pretreatment with minocycline improves neurogenesis and behavior performance after midazolam exposure in neonatal rats.

17Β-Estradiol Protects the Neonatal Brain from Hypoxia–ischemia

Repeated Administration of Ketamine Can Induce Hippocampal Neurodegeneration and Long-Term Cognitive Impairment Via the ROS/HIF-1α Pathway in Developing Rats

Neonatal Ketamine Exposure-Induced Cognitive Dysfunction Persists into Adulthood in Rats

Ketamine administered to pregnant rats in the second trimester causes long-lasting behavioral disorders in offspring

Ketamine Inhibits Neuronal Differentiation by Regulating Brain-Derived Neurotrophic Factor (BDNF) Signaling

Prenatal ketamine exposure causes abnormal development of prefrontal cortex in rat

Dexmedetomidine Protects Neural Stem Cells from Ketamine-Induced Injury.

Ketamine Administered Pregnant Rats Impair Learning and Memory in Offspring Via the Creb Pathway

Ketamine Enhances Human Neural Stem Cell Proliferation and Induces Neuronal Apoptosis Via Reactive Oxygen Species–Mediated Mitochondrial Pathway

Effects of ketamine on the cognitive function and hippocampus synaptophysin expression in neonatal rats

Effects of ketamine on the neurons apoptosis and NMDAR-2B expression in neonatal rats hippocampal CA3 area

Reactive Oxygen Species-mediated Loss of Phenotype of Parvalbumin Interneurons Contributes to Long-term Cognitive Impairments after Repeated Neonatal Ketamine Exposures